1 ------ U.S. SECURITIES AND EXCHANGE COMMISSION ------------------------------ FORM 4 WASHINGTON, D.C. 20549 OMB APPROVAL ------ ------------------------------ STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OMB Number: 3/235-0287 [ ] Check this box if no Expires: September 30, 1998 longer subject to Filed pursuant to Section 16(a) of the Securities Estimated average burden Section 16. Form 4 Exchange Act of 1934, Section 17(a) of the hours per response.........0.5 or Form 5 obligations Public Utility Holding Company Act of 1935 ------------------------------ may continue. See or Section 30(f) of the Investment Company Instruction 1(b). Act of 1940 (Print or Type Responses) ------------------------------------------------------------------------------------------------------------------------------------ 1. Name and Address of Reporting Person* 2. Issuer Name and Ticker or Trading Symbol 6. Relationship of Reporting Person(s) Quinn Michael J. Eclipse Surgical Technologies, Inc./ to Issuer (Check all applicable) -------------------------------------------- ESTI (Nasdaq) X Director 10% Owner (Last) (First) (Middle) ---------------------------------------------- ---- --- c/o Eclipse Surgical Technologies, Inc. 3. IRS or Social Security 4. Statement for X Officer Other (specify 1049 Kiel Court Number of Reporting Month/Year ---- --- below) -------------------------------------------- Person (Voluntary) February 2001 (give title below) (Street) ------------------- Chief Executive Officer, President and Chairman of the Board Sunnyvale CA 94089 5. If Amendment, ------------------------------------ -------------------------------------------- Date of Original (City) (State) (Zip) (Month/Year) 7. Individual or Joint/Group Reporting (Check applicable line) ------------------- X Form filed by One ---- Reporting Person Form filed by More Than ---- One Reporting Person ------------------------------------------------------------------------------------------------------------------------------------ TABLE I -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6. Ownership 7. Nature of (Instr. 3) action action or Disposed of (D) Securities Form: Indirect Date Code (Instr. 3, 4 and 5) Beneficially Direct Beneficial (Instr. 8) Owned at (D) or Ownership (Month/ end of Month Indirect (Instr. 4) Day/ --------------------------------------- (Instr. 3 and 4) (I) Year) Code V Amount (A) or Price (Instr. 4) (D) ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 2/12/01 P 20,000 A $2.09 30,000 D ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Over) *If the form is filed by more than one reporting person, see instruction 4(b)(v). SEC 2270 (7/96)

ECLIPSE SURGICAL TECHNOLOGIES INC 4